U.S., Nov. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07938866) titled 'Genomic Predictors of Response to CAR-T and BiTE Therapies in B-cell Non-Hodgkin Lymphomas' on Nov. 10.
Brief Summary: The purpose of this prospective, non-therapeutic study is to evaluate molecular and clinical factors associated with clinical outcomes following CD19-directed chimeric antigen receptor T-cell (CAR-T) therapy and bispecific T-cell engager (BiTE) therapies in patients with relapsed or refractory B-cell non-Hodgkin lymphoma (R/R NHL).
Study Start Date: Nov. 15
Study Type: OBSERVATIONAL
Condition:
Non-Hodgkin Lymphoma Refractory/ Relapsed
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Duke University
Published b...